Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Reexamination Certificate
2005-08-23
2005-08-23
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
C568S585000
Reexamination Certificate
active
06933322
ABSTRACT:
This invention provides compounds of formula I, having the structurewherein R1, R4, A, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof, that are useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia.
REFERENCES:
Mosmann, Journal of Immunological Methods, 65, 55-63 (1983).
Goodman, Michael, Biochem. J., 150, 137-139 (1975).
Lowry, et al., J. Biol. Chem., 193, 265-275 (1951).
Jomain-Baum et al., The Journal of Biological Chemistry, 251(1), 37-44 (1976).
Consoli, et al., Diabetes, 38, 550-557 (1989).
Chang et al., Diabetes, 32, 830-838 (1983).
Brichard, et al., Diabetes, 39, 1326-1332 (1990).
O'Brien, et al., Diabetes Care, 13(3), 327-339 (1990).
Coleman, Diabetologia, 14, 141-148 (1978).
Heding, Diabetologia, 8, 260-266 (1972).
Smith et al., Analytical Biochemistry, 150, 76-85 (1985).
Hardman et al., Methods in Enzymology, vol. XXXIX, Part D, 25-36 (1975).
Vranckx, et al., Biochemistry and Molecular Biology, vol. 65, 55-63 (1983).
Antane Schuyler
Caufield Craig E.
Greenfield Alexander A.
Morrison Eamonn P.
Sabatucci Joseph P.
Fish & Richardson P.C.
Solola Taofiq
Wyeth
LandOfFree
Substituted naphthylenes for the treatment of non-insulin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted naphthylenes for the treatment of non-insulin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted naphthylenes for the treatment of non-insulin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3494878